Hemobiotech, Inc. (GM CE)
Ticker Symbol: USOTC:HMBT
OTC Market Tier: Grey Market
CIK Number: 0001301348
Security Type: Common Stock
HMBT Address: 5001 Spring Valley Road
Suite 1040
Dallas, Texas 75244
HMBT Country: USA
HMBT Phone: 972-455-8950
HMBT Fax #: N/A
Website: http://www.hemobiotech.com
Description: N/A
SIC Code / Description: 2836 / Biological products, except diagnostic
Shares Authorized:
Shares Outstanding: 20,120,791
Shares Outstanding Date: 08/06/2008
Shares Holder Count: 73
Shares Holder Date: 03/28/2008
Market Capitalization: $ 20,120.79
Key Executives: Arthur Bollon - Dir.
Robert Comer - Interim CFO
Robert E. Dragoo - Dir.
Robert Baron - Chairman
Number of Employees: N/A
Incorporation State: Delaware
Incorporation Country: USA
Incorporation Year: N/A
Auditor: N/A
IR Firm: N/A
Legal Counsel: N/A
Fiscal Year End: 12/31
Reporting Status: SEC Reporting
Bankrupt: No
Shell: No
Audit Status: No
ADR Ratio: N/A
Transfer Agent: N/A
Depository Website: N/A
SHO Flag: N/A
3210 Flag: N/A
Short Volume: 0
Short Date: 05/31/2012
Closing MMID:
Tier ID: 30
Status: Revoked

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.